What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Selecting the right IRA type for index funds hinges on your tax picture, contribution goals, and retirement timeline.
24,087 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
BNY Mellon posted stronger margins and revenue growth than State Street in Q1 2026, signaling a platform-led edge as ...
A striking insider move from Elevance Health’s chairman raises questions for investors. This article breaks down what...
A strategic, high-yield dividend can become a reliable pillar in retirement. Learn how to evaluate safety, diversify,...
NuScale Power faces a high-stakes decade as regulators, financiers, and utilities weigh SMR potential. This article l...
Stock splits often signal strong momentum. Here are three stock-split stocks before they soar, with practical analysi...
The Congressional Budget Office now projects the Old-Age and Survivors Insurance Trust Fund could deplete by 2032, on...
Reading an earnings transcript can reveal how a company leverages international markets. This guide uses NPK Internat...
As policymakers push a universal 401(K) plan, the trump’s universal 401(k) architect outlines the trust challenges fa...
On a day when the market generally slipped, Plug Power captured attention with a solid quarterly report. This piece b...
One token surged over 18% in a single session, even as the broader market dipped. This guide breaks down why these mo...
When a top executive sells a large block of shares, investors want clarity. This guide breaks down what RingCentral's...